Position in BIIB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$26,481,647
+$1,601,241 QoQ
Shares Held
144,448
+2.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 78.31745680106336.ToString("F0")%
Shared 0.ToString("F0")%
None 21.682543198936642.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $19,026,917,368 across 16 Drug Manufacturers - General names. BIIB ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,471,778 | $4,113,007,243 | |
| 2 | AZN |
Astrazeneca PLC
|
17,792,161 | $3,508,969,981 | |
| 3 | ABBV |
AbbVie Inc.
|
14,552,069 | $3,164,929,479 | |
| 4 | JNJ |
Johnson & Johnson
|
10,474,706 | $2,560,437,127 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,267,205 | $1,956,782,081 | |
| 6 | PFE |
Pfizer Inc
|
28,341,834 | $795,838,692 | |
| 7 | NVO |
Novo Nordisk A S
|
16,083,479 | $591,067,849 | |
| 8 | AMGN |
Amgen Inc
|
1,500,535 | $527,963,233 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,481,647 | 144,448 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $24,880,406 | 141,374 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $32,100,167 | 229,156 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,761,362 | 229,010 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $80,477,926 | 588,117 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $60,310,268 | 394,391 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $72,640,954 | 374,747 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $90,055,112 | 388,470 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $83,143,259 | 385,583 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $128,957,768 | 498,349 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $161,539,521 | 628,534 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $126,129,297 | 442,792 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $118,353,476 | 425,686 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $116,883,499 | 422,084 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $109,267,614 | 409,242 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $84,196,423 | 412,849 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $87,479,448 | 415,382 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $110,718,760 | 461,482 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $137,616,619 | 486,295 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $163,197,048 | 471,300 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $148,345,547 | 530,279 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $116,027,398 | 473,852 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $168,590,170 | 594,297 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $154,449,387 | 577,273 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $204,404,256 | 646,072 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||